vs
布鲁克（BRKR）与Prenetics Global Ltd（PRE）财务数据对比。点击上方公司名可切换其他公司
布鲁克的季度营收约是Prenetics Global Ltd的227.5倍（$977.2M vs $4.3M）
布鲁克公司是美国科学仪器制造商，总部位于马萨诸塞州比勒里卡，为公开上市企业。公司产品服务于分子与材料研究、工业及应用分析领域，旗下设有布鲁克科学仪器、布鲁克能源与超导技术（BEST）两大业务板块。
Prenetics是一家总部位于中国香港的健康科学企业，业务辐射美国地区，专注于癌症等疾病的早期筛查、预防与干预诊疗，致力于帮助人们更早发现健康风险，助力提升相关疾病的治疗效果，推动肿瘤等重疾的早防早治，守护公众健康。
BRKR vs PRE — 直观对比
营收规模更大
BRKR
是对方的227.5倍
$4.3M
损益表 — Q4 2025 vs Q3 2023
| 指标 | | |
|---|---|---|
| 营收 | $977.2M | $4.3M |
| 净利润 | $26.0M | — |
| 毛利率 | 46.0% | 44.9% |
| 营业利润率 | 7.8% | -396.2% |
| 净利率 | 2.7% | — |
| 营收同比 | -0.2% | — |
| 净利润同比 | 89.8% | — |
| 每股收益（稀释后） | $0.10 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BRKRPRE
| Q4 25 | $977.2M | — | ||
| Q3 25 | $860.5M | — | ||
| Q2 25 | $797.4M | — | ||
| Q1 25 | $801.4M | — | ||
| Q4 24 | $979.6M | — | ||
| Q3 24 | $864.4M | — | ||
| Q2 24 | $800.7M | — | ||
| Q1 24 | $721.7M | — |
净利润BRKRPRE
| Q4 25 | $26.0M | — | ||
| Q3 25 | $-59.6M | — | ||
| Q2 25 | $7.6M | — | ||
| Q1 25 | $17.4M | — | ||
| Q4 24 | $13.7M | — | ||
| Q3 24 | $40.9M | — | ||
| Q2 24 | $7.6M | — | ||
| Q1 24 | $50.9M | — |
毛利率BRKRPRE
| Q4 25 | 46.0% | — | ||
| Q3 25 | 44.1% | — | ||
| Q2 25 | 44.9% | — | ||
| Q1 25 | 48.8% | — | ||
| Q4 24 | 50.4% | — | ||
| Q3 24 | 48.4% | — | ||
| Q2 24 | 48.0% | — | ||
| Q1 24 | 48.9% | — |
营业利润率BRKRPRE
| Q4 25 | 7.8% | — | ||
| Q3 25 | -6.0% | — | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | 4.0% | — | ||
| Q4 24 | 7.4% | — | ||
| Q3 24 | 7.9% | — | ||
| Q2 24 | 6.0% | — | ||
| Q1 24 | 9.0% | — |
净利率BRKRPRE
| Q4 25 | 2.7% | — | ||
| Q3 25 | -6.9% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | 1.4% | — | ||
| Q3 24 | 4.7% | — | ||
| Q2 24 | 0.9% | — | ||
| Q1 24 | 7.1% | — |
每股收益（稀释后）BRKRPRE
| Q4 25 | $0.10 | — | ||
| Q3 25 | $-0.41 | — | ||
| Q2 25 | $0.05 | — | ||
| Q1 25 | $0.11 | — | ||
| Q4 24 | $0.09 | — | ||
| Q3 24 | $0.27 | — | ||
| Q2 24 | $0.05 | — | ||
| Q1 24 | $0.35 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $298.8M | — |
| 总债务越低越好 | $1.9B | — |
| 股东权益账面价值 | $2.5B | — |
| 总资产 | $6.2B | — |
| 负债/权益比越低杠杆越低 | 0.76× | — |
8季度趋势，按日历期对齐
现金及短期投资BRKRPRE
| Q4 25 | $298.8M | — | ||
| Q3 25 | $293.1M | — | ||
| Q2 25 | $92.0M | — | ||
| Q1 25 | $184.2M | — | ||
| Q4 24 | $183.4M | — | ||
| Q3 24 | $148.1M | — | ||
| Q2 24 | $169.7M | — | ||
| Q1 24 | $340.1M | — |
总债务BRKRPRE
| Q4 25 | $1.9B | — | ||
| Q3 25 | $2.0B | — | ||
| Q2 25 | $2.4B | — | ||
| Q1 25 | $2.1B | — | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.2B | — | ||
| Q1 24 | $1.4B | — |
股东权益BRKRPRE
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $1.8B | — | ||
| Q4 24 | $1.8B | — | ||
| Q3 24 | $1.8B | — | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | $1.4B | — |
总资产BRKRPRE
| Q4 25 | $6.2B | — | ||
| Q3 25 | $6.4B | — | ||
| Q2 25 | $6.3B | — | ||
| Q1 25 | $5.9B | — | ||
| Q4 24 | $5.8B | — | ||
| Q3 24 | $6.1B | — | ||
| Q2 24 | $5.9B | — | ||
| Q1 24 | $4.5B | — |
负债/权益比BRKRPRE
| Q4 25 | 0.76× | — | ||
| Q3 25 | 0.83× | — | ||
| Q2 25 | 1.34× | — | ||
| Q1 25 | 1.15× | — | ||
| Q4 24 | 1.18× | — | ||
| Q3 24 | 1.27× | — | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 0.97× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $229.8M | — |
| 自由现金流经营现金流 - 资本支出 | $207.2M | — |
| 自由现金流率自由现金流/营收 | 21.2% | — |
| 资本支出强度资本支出/营收 | 2.3% | — |
| 现金转化率经营现金流/净利润 | 8.84× | — |
| 过去12个月自由现金流最近4个季度 | $43.3M | — |
8季度趋势，按日历期对齐
经营现金流BRKRPRE
| Q4 25 | $229.8M | — | ||
| Q3 25 | $-33.2M | — | ||
| Q2 25 | $-127.5M | — | ||
| Q1 25 | $65.0M | — | ||
| Q4 24 | $190.0M | — | ||
| Q3 24 | $38.4M | — | ||
| Q2 24 | $1.1M | — | ||
| Q1 24 | $21.8M | — |
自由现金流BRKRPRE
| Q4 25 | $207.2M | — | ||
| Q3 25 | $-54.1M | — | ||
| Q2 25 | $-148.8M | — | ||
| Q1 25 | $39.0M | — | ||
| Q4 24 | $153.3M | — | ||
| Q3 24 | $5.8M | — | ||
| Q2 24 | $-23.5M | — | ||
| Q1 24 | $400.0K | — |
自由现金流率BRKRPRE
| Q4 25 | 21.2% | — | ||
| Q3 25 | -6.3% | — | ||
| Q2 25 | -18.7% | — | ||
| Q1 25 | 4.9% | — | ||
| Q4 24 | 15.6% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | -2.9% | — | ||
| Q1 24 | 0.1% | — |
资本支出强度BRKRPRE
| Q4 25 | 2.3% | — | ||
| Q3 25 | 2.4% | — | ||
| Q2 25 | 2.7% | — | ||
| Q1 25 | 3.2% | — | ||
| Q4 24 | 3.7% | — | ||
| Q3 24 | 3.8% | — | ||
| Q2 24 | 3.1% | — | ||
| Q1 24 | 3.0% | — |
现金转化率BRKRPRE
| Q4 25 | 8.84× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -16.78× | — | ||
| Q1 25 | 3.74× | — | ||
| Q4 24 | 13.87× | — | ||
| Q3 24 | 0.94× | — | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 0.43× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BRKR
| Bsi Nano | $309.1M | 32% |
| Bsi Biospin | $267.0M | 27% |
| Other | $179.9M | 18% |
| Transferred Over Time | $142.5M | 15% |
| Energy And Supercon Technologies | $69.5M | 7% |
PRE
暂无分部数据
